This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Contraindication regarding the use of VOLIBRIS (ambrisentan) in patients with Idiopathic Pulmonary Fibrosis (IPF). Internet Document: 9 Jul 2012. Available from: URL: http://www.hc-sc.gc.ca
About this article
Cite this article
GlaxoSmithKline, in consultation with Health Canada, has issued a letter to healthcare professionals regarding ambrisentan [Volibris].. React. Wkly. 1411, 4 (2012). https://doi.org/10.2165/00128415-201214110-00007
- Public Health
- Connective Tissue
- Placebo Group